IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Amazing Benefits of Myrrh

Author: ROSE ABUKHADER, ABDEL RAHMAN AL TAWAHA
Abstract: Myrrh is the resin derived from the branches and stems of a tree, known as Commiphora myrrha. It is Native to East/Northeast Africa, Southwest Asia (particularly Ethiopia, Somalia, and Kenya) and Arabia, Myrrha is usually imported as gum. Myrrha is considered as herbal medicine, myrrh, an oleo-reddish-brown gum resin, has a valuable role. After making incisions in the stem of the plant, causing oleoresin to exude and dry, it is extracted from the medicinal plant Commiphora myrrha. Pharmacological research has indicated that myrrh has analgesic, anti-inflammatory, antiviral, antimicrobial, immunomodulatory, and hepatoprotective functions. The word Myrrh is derived from the Arabic "murr" meaning bitter, and its functions have been documented in the writings of Hippocrates since the time of ancient Rome. This material is marketed worldwide as a pharmaceutical plant, and customers purchase it because of its multiple benefits, having been licensed by the Food and Drug Admiration (FDA) for food use. In Arabia, Somali land, India, Ethiopia, Abyssinia, and to some degree in Northern Kenya, the tropical tree, Commiphora myrrha, grows. The use of myrrh in the treatment of pulmonary problems such as respiratory infections, in particular asthma, chronic cough, diphtheria, pharyngitis, tonsillitis, common cold, and bronchitis, and in gastrointestinal and genitourinary disorders has been identified by many Chinese, Unani, and Arabic physicians since 600 AD. The focus of this review is the immunoregulatory potential of the bioactive components of Commiphora myrrha and their efficacy in reducing inflammation risk.
Keyword: Commiphora myrrha, Myrrh, Immunomodulation, Anti-Inflammation, Cytokines Storm, Covid-19.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.069
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free